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660Dystrophic Epidermolysis Bullosa: COL7A1
Mutation Landscape in a Multi-Ethnic
Cohort of 152 Extended Families with
High Degree of Customary
Consanguineous Marriages
Hassan Vahidnezhad1,2,11, Leila Youssefian1,3,11, Sirous Zeinali2,4, Amir Hossein Saeidian1,
Soheila Sotoudeh5, Nikoo Mozafari6, Maryam Abiri2,3,4, Abdol-Mohammad Kajbafzadeh7,
Mohammadreza Barzegar6, Adam Ertel8, Paolo Fortina8,9 and Jouni Uitto1,10Dystrophic epidermolysis bullosa is a heritable skin disease manifesting with sub-lamina densa blistering,
erosions, and chronic ulcers. COL7A1, encoding type VII collagen, has been identified as the candidate gene
for dystrophic epidermolysis bullosa. In this study, we have identified COL7A1mutations in a large multi-ethnic
cohort of 152 extended Iranian families with high degree of consanguinity. The patients were diagnosed by
clinical manifestations, histopathology, and immunoepitope mapping. Mutation detection consisted of a
combination of single nucleotide polymorphism-based whole-genome homozygosity mapping, Sanger
sequencing, and gene-targeted next-generation sequencing. A total of 104 distinct mutations in COL7A1 were
identified in 149 of 152 families (98%), 56 (53%) of them being previously unreported. Ninety percent of these
mutations were homozygous recessive, reflecting consanguinity in these families. Three recurrent mutations
were identified in five or more families, and haplotype analysis suggested a founder effect in two of them. In
conclusion, COL7A1 harbored mutations in the overwhelming majority of patients with dystrophic epi-
dermolysis bullosa, and most of them in this Iranian cohort were consistent with autosomal recessive inheri-
tance. The mutation profile attests to the impact of consanguinity in these families.
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The heritable forms of epidermolysis bullosa (EB) comprise a
heterogeneous group of disorders with the clinical hallmark
of blistering of the skin and the mucous membranes (Fine
et al., 2014; Uitto et al., 2016b). The diagnosis is character-
istically made at birth or shortly thereafter, but the subsequent
progression of the disease and the overall prognosis can be
highly variable depending, in part, on the underlying mo-
lecular defects, which have now been identified in as many
as 18 different genes expressed in the dermal-epidermal
junction (Uitto et al., 2016a, 2016b). EB has been classified
into four broad categories based on the topographic location
of the blistering within the cutaneous basement membrane
zone. The phenotypic, both intra- and interfamilial, vari-
ability in these different forms of EB reflects the physiological
functions of the proteins encoded by the mutated genes, the
types and combinations of the mutations, and the influence
of the environmental factors, particularly trauma and
infections. In the most severe cases, EB can be lethal during
the early days or weeks of life, whereas in some forms the
disease manifests with protracted, life-long blistering
tendency without affecting the longevity of the individual.
One of the four subtypes of EB is the dystrophic variant
(DEB) (OMIM: 131750 and 226600) characterized by sub-
lamina densa blistering leading to erosions, poorly healinguthors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
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COL7A1 Mutations in DEBchronic ulcers, and extensive scarring, particularly at the sites
of trauma on the hands and feet. Blistering can also occur in
cornea and the gastrointestinal epithelium, and patients often
experience scarring of the esophagus, which has clinical
consequences with respect to oral feeding (Fine and Mellerio,
2009). Patients frequently develop an aggressive squamous
cell carcinoma, leading to early death from metastases
(Montaudie et al., 2016). DEB is caused by mutations in
COL7A1, the gene encoding type VII collagen, a major
protein component of the anchoring fibrils that play a critical
role in securing the attachment of the dermal-epidermal
basement membrane to the underlying dermis (Chung and
Uitto, 2010). Electron microscopic examination of the
anchoring fibrils in patients with DEB can show morpho-
logical alterations, reduction in their number, or complete
absence, which correlate to a certain degree with phenotypic
severity of the disease. DEB can be inherited in either an
autosomal dominant (DDEB) or autosomal recessive (RDEB)
fashion, the clinical manifestations in RDEB being charac-
teristically more severe, reflecting in many cases complete
absence of the anchoring fibrils. RDEB has been divided into
generalized severe (previously known as the Hallopeau-
Siemens type) and generalized other (formerly called the
noneHallopeau-Siemens type) (Fine et al., 2014).
In this study, we examined a large multi-ethnic cohort of
DEB patients in Iran, a country of approximately 80 million
inhabitants, where consanguineous marriages are frequent. In
fact, approximately 38% of all Iranian marriages are consan-
guineous, with a mean inbreeding coefficient (alpha) of
0.0185 (Saadat et al., 2004). First cousin marriages (28%) are
the most common form of consanguineous unions (Saadat
et al., 2004). The Iranian population includes several ethnic
groups, including Persians, Turks, Kurds, Lurs, Baluchis, Arabs,
Gilakis, Tabari, and Taleshis, all with different ancestries,
distinct linguistics, defined cultures, and limited geographic
areas of habitation. We studied the COL7A1 mutation profile
in this cohort, consisting of 238 patients representing 152
extended families with different forms of DEB. The purpose of
the study was to determine the mutation landscape with spe-
cial reference to the effect of consanguinity.
RESULTS
Patient population and DEB diagnosis
As part of our efforts to characterize a large cohort of EB
patients in Iran, 152 extended families with 238 patients
whose clinical presentation, immunoepitope and/or homo-
zygosity mapping were suggestive of DEB, were included for
COL7A1 mutational analysis. Patients with the diagnosis of
EB seen in a number of medical centers in Iran were exam-
ined for subclassification as having DEB by several criteria.
First, characteristic clinical signs consisted of blistering and
erosions, mutilating scarring of the hands and feet, corneal
involvement, poor dentition, and development of squamous
cell carcinoma (Figure 1aeh). In some of these patients,
radiological examination showed esophagus atresia
(Figure 1i). In most patients suspected of having DEB,
immunofluorescence epitope mapping was performed,
which showed sub-lamina densa blistering, and in many of
these patients staining for type VII collagen was markedly
reduced or absent (Figure 1j).Examination of the pedigrees suggested an autosomal
recessive inheritance pattern in most families but an auto-
somal dominant inheritance pattern in only one family
(Figure 1k). Among 152 families, 139 families had evidence
of consanguinity, 106 of them being first cousin marriages. In
some families, when skin biopsy sample analysis was not
informative or available from the affected individual, homo-
zygosity mapping was performed with a single nucleotide
polymorphism (SNP)-based microarray, followed by align-
ment of the homozygosity blocks with positions of 21 genes
known to be involved in different forms of EB or other skin
fragility syndromes, which are in their differential diagnosis
(Figure 1l). In a subset of patients, homozygosity mapping
was performed using six short tandem repeat markers linked
to COL7A1. Although the proband(s) showed a homozygous
haplotype pattern, their parents were heterozygotes (see
Supplementary Figure S1 online).
Demographic data showed the presence of multiple Iranian
ethnicities in our cohort of DEB patients, but the contribution
of Lurish ethnicity, an ancestral population residing primarily
in the central western part of Iran, with a strong tradition of
consanguineousmarriages,was significantly higher in theDEB
cohort than expected on the basis of their share of the total
population (Figure 1m). Severity of DEB among our inbred
cohort was markedly different from outbred populations, such
as in the United States. Although in the US patient cohort the
distribution of three major forms of DEB (i.e., RDEB general-
ized severe, RDEB generalized other, and dominant dystrophic
EB) were 9%, 33%, and 58%, respectively, in our Iranian
cohort this distribution was dramatically different and con-
sisted of 90%, 8%, and 2%, respectively. The rate of consan-
guinity among the parents of the Iranian cohort of DEB patients
was 92%, whereas the average rate of consanguinity of the
total population in the country is about 38% (Saadat et al.,
2004). The first cousin and nonconsanguineous marriages
were dramatically overrepresented and underrepresented
among the DEB patients in our cohort (69% and 8%, respec-
tively) comparedwith the general population in Iran (28% and
61%, respectively) (Figure 1o).
Mutation analysis
Type VII collagen mutations were first sought by PCR
amplification of all 118 exons and flanking intronic se-
quences, followed by bidirectional Sanger sequencing of 73
families. By this approach, COL7A1 mutations were found in
69 of these families. Subsequently, a COL7A1-targeted array
of next-generation sequencing (NGS) was designed. This
design had a 99% theoretical coverage of all coding regions
of the gene, which spans approximately 30 kilo-base pairs of
the genome in the short arm of chromosome 3 (Figure 2a).
Bioinformatics analysis with appropriate filtering showed
mutations in 95 families of the 98 tested by this approach
(96.9%). Fifteen families initially genotyped by Sanger
sequencing of the entire COL7A1 gene were included in this
panel and served as controls for the gene-targeted NGS
sequencing. All mutations disclosed by COL7A1-targeted
sequencing were verified by bidirectional Sanger sequencing,
as shown in Figure 2c.
In the total cohort of 152 families with DEB, 104 distinct
mutations inCOL7A1were detected in 149 families (detectionwww.jidonline.org 661
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Figure 1. Candidate gene identification in families with DEB by homozygosity mapping. (aej) Clinical features of patients with DEB, (k) examples of multiplex
families, (l) homozygosity mapping in a family with RDEB, (m) distribution of ethnicity of DEB patients and total population of Iran, (n) types of DEB in Iranian
versus US cohorts, and (o) degree of consanguinity among DEB patients versus the total population in Iran. (aeh) Note the characteristic phenotype with
erosions and scarring with mitten deformities of the hands and feet as well as corneal erosions and hypodontia. (i) Radiography of barium swallowing shows
esophageal strictures. (j) Immunofluorescence for type VII collagen shows markedly reduced or absent staining in RDEB patients’ skin (lower panel, the stars
indicate blistering) compared with normal skin with linear staining at the dermal epidermal junction (arrows). (k) Note the presence of multiple affected
individuals in extended families, consistent with autosomal recessive (two left pedigrees) and autosomal dominant (right pedigree) patterns. Probands are
indicated by arrowheads. (l) Genome-wide homozygosity mapping identifies multiple homozygosity blocks of >2 Mb (blue) in the autosome of a patient (in f)
with consanguineous parents with coefficient of inbreeding (of 0.1093). Alignment of multiple genes associated with heritable blistering diseases (red lines)
shows an overlap with LAMC2 and COL7A1 with a homozygosity block in chromosome 3, identifying them as candidate genes in this family. (m) Among the
Iranian ethnicities, the Lurish have a higher percentage of DEB patients than expected from their presence in the total population in Iran. (n) The Iranian DEB
population studied in this cohort consists predominantly of patients with RDEB generalized severe (90%) disease, whereas only 2% of patients have dominant
dystrophic EB. This distribution dramatically differs from that in the United States. (o) The impact of consanguinity on DEB is illustrated by the percentages of first
and second cousin parents of the Iranian DEB patients (89%), as opposed to the degree of consanguinity in the total population in Iran, where 61% of married
couples have no family relationship. DEB, dystrophic epidermolysis bullosa; EB, epidermolysis bullosa; RDEB, recessive dystrophic epidermolysis bullosa; Mb,
mega-base pair.
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Figure 2. Schematic design of COL7A1-targeted next-generation sequencing array. (a) COL7A1 consists of 118 exons in the chromosomal region 3p21.31.
Amplicon design resulted in approximately 99% coverage of the coding regions and of 100 base pairs of flanking intronic sequences. The coverage of families 7
and 27 is shown as an illustration of mutation detection, which shows c.461del76 and c.1637-240_3255del4063 deletion mutations spanning from exon 4 to
intron 4 and from intron 12 to exon 24, respectively. (b) This approach identified recessive homozygous mutations in 90% of the families. (c) These mutations
were confirmed by Sanger sequencing. Of the 104 mutations identified by this array or by Sanger sequencing of PCR amplified exons and flanking intronic
sequences, 56% were previously unreported; distribution of splicing, nonsense, missense, and indel mutations is indicated.
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COL7A1 Mutations in DEBrate of 98%) by combined Sanger sequencing and gene-
targeted NGS (Figure 3, and see Supplementary Table S1 on-
line). The genetic variants included missense (31), nonsense
(24), and splice junction (17) mutations, as well as large and
small indel mutations (32) resulting in premature termination
codon (Figures 2c and 3, and see Supplementary Tables S2 and
S3 online). The missense mutations substituting glycine resi-
dues in the collagenous domain are likely to result in desta-
bilization of the triple helical conformation (Christiano et al.,
1996), and the mutations within the NC1 domain may inter-
fere with the interactions of type VII collagen with type IV
collagen and laminin 332, components of the cutaneous
basement membrane zone (Brittingham et al., 2006; Chen
et al., 1999). Among the 104 distinct mutations identified, 56
were previously unreported to our knowledge, and 48 have
been reported before. Most nonsense mutations (75%) were
previously reported while most indel mutations (69%) were
previously unreported to our knowledge (Figure 2c, and see
Supplementary Table S1). Among the 149 families in which
mutations in COL7A1 were detected, 134 families had bial-
lelic mutations consistent with autosomal recessive inheri-
tance (90%) (Figure 2b). One family had a constellation and
mutation analysis, heterozygous c.5264G>A, p.Gly1755Asp
(family no. 77, Figure 1k, right panel), and in one family
(no. 95) the heterozygous COL7A1 mutation c.6119G>T,
p.Gly2040Ser was de novo, not present in the parents of the
proband, consistent with dominant dystrophic EB (Christiano
et al., 1996). Thus, the overwhelming majority (90%) of DEBfamilies in this Iranian cohort showed homozygous recessive
mutations, apparently reflecting consanguinity in this popu-
lation (Figure 2b).
Among 152 families examined, consanguinity was evident
in 139 families. Mutation analysis showed homozygous
recessive mutations in 132 of them; in four consanguineous
families, the mutations were compound heterozygous; and in
three families no COL7A1 mutations were detected. In 13
families, there was no obvious relationship between the
parents of the proband, and nine of them had compound
heterozygous mutations, only two of them being homozy-
gous recessive. These observations re-emphasize the influ-
ence of consanguinity in determining the types of genetic
variants disclosed in rare heritable diseases, as illustrated
here by RDEB (see Supplementary Table S2).
Recurrent mutations and evidence for founder effect
A number of mutations detected in COL7A1 in our patient
cohort were recurrent, and 30 of them were found in two or
more independent, unrelated families. The three most
frequent recurrent mutations were c.6269_6270delC,
p.Pro2090LeufsX116; c.4233delT, p.P1411PfsX298; and
c.553C>T, p.Arg185X, which were detected in 18, five, and
five distinct unrelated families, respectively (a total of 19% of
all families) (Figure 3, and see Supplementary Table S1).
Geographic distribution of the mutations within the Iranian
national borders showed that the c.6269_6270delC muta-
tion, found in 18 families, was concentrated on the westernwww.jidonline.org 663
Figure 3. Organization of type VII collagen cDNA consisting of 118 exons, with positions of the mutations identified in this study. Missense mutations are
below and premature termination causing mutations are above the cDNA. The mutations in red are previously unreported to our knowledge, whereas mutations
in black have been reported previously. The number in parentheses after each mutation indicates the number of families harboring this mutation. The protein
domains of type VII collagen encoded by COL7A1 are identified by color code below the gene.
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664part of the country, extending from northwest to southwest
within a distance of about 960 miles (1,500 km) (Figure 4).
These 18 families belong to either Lurish (eight), Turkish
(eight), or Persian (two) ethnicities. The c.4233delT mutation
was also concentrated on the western part of Iran and was
observed exclusively in Lurish ethnicity, whereas the
p.Arg185X did not show any specific pattern of distribution
and was seen in both Persian and Turkish ethnicities
(Figure 4).
To address the question about the origin of these recurrent
mutations and to specifically investigate whether the high
frequency of these mutations was due to a founder effect and/
or a mutational hotspot, we explored evidence of shared
common haplotypes in these families by genotyping 33 SNPsJournal of Investigative Dermatology (2017), Volume 137within and in flanking regions of COL7A1 (Figure 5). A
homozygous conserved haplotype in a 4.62 mega-base pair
(Mb) genomic interval, spanning from rs12489865 to
rs614288, was observed in 13 families harboring the
c.6269_6270delC mutation. Recombinational events in three
additional families shortened the conserved homozygous
haplotype to 1 Mb genomic interval, spanning from
rs6784820 to rs11797. This common 1-Mb haplotype in
these families was absent in our in-house, ethnic-specific
control population, an observation that supports the notion
that c.6269_6270delC is a common founder mutation
(Figure 5). However, in one Persian family this haplotype was
not conserved, and this same mutation has been previously
reported in a Chinese family (Pfendner et al., 2003),
Figure 4. The geographic location of families in Iran with COL7A1 mutations identified in this study. The families harboring the recurrent mutations
c.6269_6270delC, c.4233delT, and c.553C>T are identified by yellow, blue, and red colors, respectively.
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slippage of replication due to mispairing in the tandem five
cytosines in the sequence, which can occur independently in
different families. A common conserved haplotype was
observed in all five Lurish families harboring the c.4233delT
mutation, suggesting that this mutation also originated from a
common ancestor. In contrast, two different haplotypes were
observed in the five families tested with the p.Arg185X
mutation. Four families had a common conserved haplotype,
but one family had a different haplotype, suggesting that the
p.Arg185X mutation is a hotspot event in these families (data
not shown). Supporting this conclusion is the fact that
this mutation reflects a cytosine-to-thymine transition,presumably as a result of methylation of cytosine to
5-methylcytosine, a common mechanism for human
mutations (Youssoufian et al., 1988). In fact, this mutation
mechanism has been previously reported in COL7A1 in
patients with DEB (Hovnanian et al., 1994).
DISCUSSION
This study has examined the mutation database in an
exceptionally large cohort of patients with DEB, a rare
Mendelian disorder inherited either in an autosomal domi-
nant or autosomal recessive pattern. This multi-ethnic cohort
consisted of 238 patients in 152 extended Iranian families
with a high degree of customary consanguineous marriages.www.jidonline.org 665
Figure 5. Haplotype analysis of 17 families with SNP marker array on chromosomal locus 3p21.31 on and surrounding the COL7A1 locus. Sequences within a
1 Mb haplotype block indicated conservation consistent with founder effect in patients primarily of Lurish and Turkish ethnicity. One patient with Persian
background (Family 113) had a different haplotype. A, adenine; C, cytosine; Chr., chromosome; G, guanine; MB, mega-base pair; SNP, single-nucleotide
polymorphism; T, thymine.
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666Considering the prevalence of EB, we have estimated that
there are about 200 identified families with DEB in Iran.
Thus, this study consisting of 152 families represents most of
the total DEB patient population. Mutation detection iden-
tified 104 distinct mutations in COL7A1, most these muta-
tions being previously unreported to our knowledge. Thus,
this study significantly expands the mutation database in this
disease. The mutation detection consisted of two comple-
mentary strategies allowing comparison of their efficiency
and costs. First, bidirectional Sanger sequencing of PCR
amplified exons and flanking intronic sequences was applied
to a cohort of 73 DEB patients, and 69 of these patients
(94.9%) were found to harbor mutations in COL7A1. Sub-
sequently, we developed a COL7A1-targeted NGS array,
which allowed parallel sequencing of 98 patients. Using this
approach, COL7A1 mutations were found in 95 of these
patients (96.9%), and all these mutations were verified by
bidirectional Sanger sequencing. Thus, both techniques were
equally efficient in identifying mutations in these patients,
with the overall mutation detection rate being 98%.
Considering the costs of mutation detection by these two
approaches, it is clear that the targeted gene array approach
is more cost and time effective. Specifically, the cost of PCR
amplification of 118 exons and flanking intronic sequences,
followed by Sanger sequencing, in our laboratory is
approximately $1,000 per sample (PCR material, labor,
and sequencing costs). In contrast, application of theJournal of Investigative Dermatology (2017), Volume 137COL7A1-targeted NGS array, when applied to batches of up
to 96 samples, yields results with comparable efficiency at a
cost of approximately $250 per sample. Several recent
studies have also advocated the use of whole-exome
sequencing (WES) for identification of mutations in herita-
ble skin diseases (South et al., 2015; Takeichi et al., 2013).
Although the cost of WES has recently decreased, and con-
tinues to do so, the current cost for mutation analysis by this
technique in patients with EB is several-fold higher compared
with the gene-targeted NGS approach (Rehm, 2013). WES
bioinformatics analysis of the results requires significantly
more time and effort than interrogation of a single gene. The
complexity of the WES procedures may explain, at least in
part, the observation that in one study, only approximately
25% of putative mutations in heritable diseases could be
disclosed by this approach, the number being somewhat
higher, approximately 35%, in autosomal recessive disorders
(Yang et al., 2013, 2014). Thus, a COL7A1-targeted array
approach is an expedient and cost-effective way of finding
mutations in patients in whom the diagnosis has been
ascertained on a clinical and/or immunoepitope mapping
basis. At the same time, in cases of EB patients with new
phenotypic presentations with no obvious candidate genes,
or those DEB patients in whom our approaches failed to find
COL7A1 mutations, extended EB gene-targeted array or WES
could be successful in identifying mutations at least in some
of these patients. In our study, the gene-targeted approach
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COL7A1 Mutations in DEBdid not identify COL7A1 mutations in three families despite
a clear-cut clinical diagnosis of RDEB and homozygosity
mapping focusing on COL7A1 genomic region. Failure to
detect mutations in these three families may reflect the
presence of mutations in the genetic areas not covered by the
NGS panel, including far upstream regulatory elements or
deep intronic sequences.
Iran is a multi-ethnic society with a number of ancestral
ethnicities. Occurrence of DEB was found in all major ethnic
groups, in most cases proportional to their presence in the
overall population of Iran. An exception to this was the Lurish
population, which represents approximately 6% of in-
dividuals within Iranian national borders. However, 22% of
patients with DEB were from Lurish ancestral background, a
finding that may be explained, at least in part, by the recur-
rence of certain mutations in this population. Specifically, a
distinct mutation, c.6269_6270delC was found in 18
independent families concentrated in the western part of the
country. Haplotype analysis of these families indicated
conservation of a homozygosity block surrounding the mu-
tation, suggesting a founder effect. This mutation, as well as
another recurrent mutation, c.4233delT, was particularly
prevalent in Lurish ethnicity.
Consanguineous marriage, defined as an intrafamilial
marriage between people who are second cousins or closer,
is customary in different geographic regions, particularly in
the Middle East and North and Sub-Saharan Africa (Hamamy
et al., 2011). Also, many migrant communities from these
regions now reside in Western countries with similar
customs. It is estimated that globally at least 20% of
the human population (>1.1 billion individuals) live in
communities with a preference for consanguineous marriage
and that at least 8.5% of children have consanguineous
parents (Modell and Darr, 2002). In addition to the degree of
relationship between the parents, the increase in risk of
having an affected child born to consanguineous parents
depends on population frequency of the disease allele in
inversely proportional order. The less common the disease
allele causing a recessive disorder is in the gene pool, the
greater the probability that the parents of an affected indi-
vidual are consanguineous. EB is an example of a rare
Mendelian disorder. As noted in our study, 92% of the
patients with DEB had consanguineous parents (the inci-
dence of all types of DEB in the US population ¼ 6.5 per one
million live births) (Pfendner et al., 2001). For more prevalent
Mendelian disorders, the rate of parent consanguinity is less.
For example, the consanguinity rate among the parents of
autosomal recessive nonsyndromic deafness patients from
Iran and Turkey is 73% and 70%, respectively (incidence ¼
280 per one million live births in the US population)
(Bademci et al., 2016). Similarly, in an Iranian cohort of 515
patients affected by a heterogeneous group of primary
immunodeficiency disorders, the average consanguineous
marriage rate among parents of ataxia-telangiectasia patients
was 81% (incidence ¼ 10 per million live births in the US
population) (Rezaei et al., 2006), whereas in Chediak-
Higashi syndrome, 100% of the parents are of consanguin-
eous union (about 200 cases of the conditions have been
reported worldwide) (Rezaei et al., 2006). Another example
of the effect of consanguinity in Iranian population is Kindlersyndrome, a form of EB, for which all recently reported cases
are a product of consanguineous unions (Youssefian et al.,
2015), and EB simplex, which is usually an autosomal
dominant disease but for which approximately 40% of
Iranian patients are autosomal recessive (Vahidnezhad et al.,
2016).
Identification of specific mutations in families with DEB, as
well as other heritable disorders, has several implications for
diagnostics and prognostication of the disease. In the case of
DEB, most children are born with blistering and erosions or
develop them within a few hours after birth. Considering the
spectrum of EB and the phenotypic heterogeneity in the four
principal subtypes of this group of disorders, initial subclas-
sification is difficult, hampering the prognostication of the
disease outcome. However, identification of specific muta-
tions in the candidate genes allows prognostic considerations
in general terms, which often dictate the types of approaches
to be taken to manage the patients and counteract the com-
plications of the disease (Hammersen et al., 2016; Mellerio
et al., 2016; Tamai and Uitto, 2016). Furthermore, although
EB is currently an intractable disorder, recent preclinical
studies have opened a number of new avenues for potential
treatment of these disorders, and some of these approaches
have already entered early clinical trials (Uitto et al., 2016a).
For many of these approaches, knowledge of the mutant
genes and identification of the specific mutations are pre-
requisites for the application of allele-specific precision
medicine (Uitto et al., in press). At the level of extended
families at risk for recurrence of heritable blistering diseases,
the precise knowledge of the mutations can be used for
identification of heterozygous carriers and can form the basis
for prenatal testing and preimplantation genetic diagnosis,
coupled with appropriate genetic counseling (Pfendner et al.,
2003). At the national and even global levels, an approach to
reduce the risk of rare autosomal recessive disorders is to
discourage consanguineous marriages. Although this
approach has been promoted in the Middle East (Modell and
Darr, 2002), there is recognition of the fact that consan-
guineous kinship patterns are, in many of these countries,
integral to the structure of the society, and appropriate ap-
proaches for genetic counseling must work within such so-
cietal conventions.
MATERIALS AND METHODS
Patient data
This study was approved by the institutional review board of the
Pasteur Institute of Iran, and all subjects and parents of underaged
patients gave written informed consent to participate in research and
gave their permission to publish their images. In this study, 152
extended families, including 238 DEB patients, were included for
COL7A1 mutational analysis from a large cohort of Iranian EB pa-
tients. Criteria for inclusion were clinical presentation and immu-
noepitope mapping. In consanguineous families, when clinical
presentation or immunoepitope mapping were not informative, we
used SNP-based whole-genome microarrays and short tandem
repeat marker-based homozygosity mapping for detection of
homozygosity of the 3p21.31 genomic region, which harbors
COL7A1. The details of immunoepitope mapping, short tandem
repeat homozygosity mapping, as well as PCR and Sanger
sequencing, are provided in the Supplementary Materials online.www.jidonline.org 667
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Whole-genome SNP-based homozygosity mapping was performed
by Illumina Infinum Exome-24 Bead Chip (240,000 SNP markers)
using 200 ng of genomic DNA as described by the manufacturer
(Illumina, San Diego, CA). B-allele frequency and log2R ratio were
analyzed with Illumina Genome Studio software (Illumina). The
software identified runs of homozygosity based on the presence of
homozygosity in the B-allele frequency but no change in the log2R
ratio, thus excluding regions of hemizygosity due to a deletion.
Genotyping errors and run of homozygosity interrupted by homo-
zygous deletions were manually adjusted. The SNP data were
analyzed by using PLINK (http://pngu.mgh.harvard.edu/wpurcell/
plink/ibdibs.shtml#homo), and runs of homozygosity of less than
2 Mb were eliminated. Superimposing 21 skin fragility related genes
with homozygosity blocks identified potential candidate genes for
mutational analysis.
COL7A1 custom panel design, library preparation, and NGS
Targeted sequencing of COL7A1 was performed on the Ion Torrent
PGM platform, using an AmpliSeq 3-pool primer design intended to
capture all COL7A1 exons plus 100 base pairs of flanking intronic
sequences. (For details of NGS using custom panel-targeted
sequencing on the Ion Torrent PGM platform, see Cao et al. [2014]
and Millat et al. [2014a, 2014b]). The panel consisted of three
separate PCR primer pools, which covered 99.9% of the 25,114
target bases and produced a total of 187 amplicons. An aliquot of
each DNA sample (20 ng) was used for library construction by an Ion
AmpliSeq Library Kit v2.0 (Life Technologies, Carlsbad, CA) accord-
ing to the manufacturer’s instructions. Samples were distinguished by
unique barcodes (Ion Xpress Barcode Adapters Kit; Life Technologies)
and then pooled in equimolar concentrations. Genomic DNA from
14 samples were loaded on an Ion 318 Chip (Thermo Fisher Scien-
tific,Waltham,MA). Alignment to hg19 genome and germline variant
calling were performed using the Torrent Suite software (Applied
Biosystem, Foster City, CA) with variant caller plugin, version 4.4.
Validation studieswere performedbybidirectional Sanger sequencing
for the pathogenic variants. Genome annotations (hg19 coordinates
for COL7A1: Chromosome 3: 48601506-48632593) and predicted
variant effects were appended to variant results using Annovar
software (http://annovar.openbioinformatics.org). In addition, SIFT
(sift.bii.a-star.edu.sg) and Polyphen2 (genetics.bwh.harvard.edu/
pph2) were used to estimate evolutionary conservation and the effects
of the amino acid substitutions on the structure and function of the
protein (see Supplementary Table S3). Sequence variants were
compared with The Database of Short Genetic Variation, Build 147
(www.ncbi.nlm.nih.gov/projects/SNP), 1000 Genomes (www.1
000genomes.org), and mutations reported in the current literature
(www.col7.info andwww.ncbi.nlm.nih.gov/pubmed/). Mutations not
reported previously were screened by our in-house ethnic-specific
control panel to rule out the presence of these SNPs in the normal
population. Mutations were annotated using nomenclature recom-
mended by the Human Genome Variation Society (www.hgvs.org/
mutnomen), and the variants were reported in reference to
NM_000094 (cDNA) and NP_000085 (protein).
Haplotype analysis
We used HapMap data to choose tag SNPs, representative SNPs with
high linkage disequilibrium that represent the haplotype, spanning a
region of about 15.5 Mb encompassing locations upstream and
downstream of COL7A1 (http://snpinfo.niehs.nih.gov/snpinfo/
snptag.htm) and (https://www.ncbi.nlm.nih.gov/variation/tools/Journal of Investigative Dermatology (2017), Volume 1371000genomes/). We also selected two common intragenic poly-
morphisms as tagSNPs, exon 14: c.1784C>T, p.Pro595Lys
(rs2228561) and exon 21: c.2844A>G, p.Pro939Pro (rs1264194),
which were previously detected by sequencing in the course of the
mutational screening of subjects and also were observed in the
Iranian control population (Minor allele frequencies: 0.10 (adenine)
and 0.32 (thymine), respectively). Altogether, 33 SNPs spanning
15.5 Mb of the COL7A1 region were genotyped by PCR and bidi-
rectionally sequenced using an automated sequencer (3730;
Applied Biosystems, Foster City, CA).
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